Meningococcemia medical therapy: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Meningococcemia}} {{CMG}}; '''Associate Editor(s)-In-Chief:''' {{CZ}} ==Overview== ==References== {{reflist|2}} {{WikiDoc Help Menu}} {{WikiDoc Sources}} [[Category:Dise...")
 
Line 3: Line 3:


==Overview==
==Overview==
==Treatment==
===Acute Pharmacotherapies ===
* [[Cephalosporin]] CSF penetration: [[cefuroxime]] 11-14 %; [[ceftriaxone]] 1.5-7%, [[cefotaxime]] 4-54%, and [[ceftazidime]] 14%.
* [[Ceftriaxone]] CSF half life approximately 5 hours.
* Potential antibiotics include [[cephalosporin]]s, [[penicillin]], and [[chloramphenicol]].
* Therapy may be as brief as 10 to 14 days in fully sensitive organisms.
* Steroid use particularly in [[purpura fulminans]] and [[adrenal hemorrhage]] ([[Waterhouse-Friderichsen syndrome]]) is controversial.
===Prophylaxis===
* [[Rifampin]] 600 mg PO q12h x 4 doses total or alternatively [[ciprofloxacin]] 500 mg PO x 1 in patients over 18 who cannot tolerate [[rifampin]]


==References==
==References==

Revision as of 21:19, 8 February 2012

Meningococcemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Meningococcemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Meningococcemia medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Meningococcemia medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Meningococcemia medical therapy

CDC on Meningococcemia medical therapy

Meningococcemia medical therapy in the news

Blogs on Meningococcemia medical therapy

Directions to Hospitals Treating Meningococcemia

Risk calculators and risk factors for Meningococcemia medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

Treatment

Acute Pharmacotherapies

Prophylaxis

References


Template:WikiDoc Sources